Dmitry Balyasny’s NeueHealth NEUE Stock Holding History

Dmitry Balyasny’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-457	Closed	-$23.8K	–	3234
2022 Q4	$23.8K	Buy	+457	New	+$33.2K	﹤0.01%	2461

Other funds holding NEUE

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

MCAV

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dmitry Balyasny's NEUE Position: Q1 2023 in Review

Dmitry Balyasny sold out of NeueHealth (NEUE) in Q1 2023, closing a stake of 457 shares — an estimated $23.8K sold.

Dmitry Balyasny first reported a position in NEUE in Q4 2022 and held it in 1 quarter. The position peaked at $23.8K in Q4 2022. 108 funds tracked by Wall St. Rank hold NEUE as of Q1 2023.

Dmitry Balyasny reported no remaining NeueHealth position as of Q1 2023 after selling out during the quarter.
Dmitry Balyasny sold 457 NeueHealth shares in Q1 2023, an estimated $23.8K.
Dmitry Balyasny first reported a position in NeueHealth in Q4 2022 and held it in 1 quarter.
Dmitry Balyasny's NeueHealth position peaked at $23.8K in Q4 2022.
108 funds tracked by Wall St. Rank held NeueHealth as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.